Systemic inflammation predicts all-cause mortality: A glasgow inflammation outcome study

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Proctor, Michael J ^a   McMillan, Donald C ^a   Horgan, Paul G ^a   Fletcher, Colin D ^b   Talwar, Dinesh ^b   Morrison, David S ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; SERUM ALBUMIN;

AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLASGOW PROGNOSTIC SCORE; HUMAN; INFLAMMATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; NEUTROPHIL COUNT; PREDICTION; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SURVIVAL RATE; THROMBOCYTE COUNT; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; CYTOLOGY; FOLLOW UP; LEUKOCYTE COUNT; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; SURVIVAL ANALYSIS; THROMBOCYTE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PLATELETS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPHILS; PLATELET COUNT; PROGNOSIS; SERUM ALBUMIN; SURVIVAL ANALYSIS;

EID: 84923821047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116206     Document Type: Article

References (32)

1. McMillan DC (2012) The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer Treat.Rev. 39:534-40. doi: 10.1016/j.ctrv.2012.08.003 PMID: 22995477
2. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, et al. (2013) The systemic inflamma-tion-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit Rev.Oncol.Hematol. 88:218-30. doi: 10.1016/j.critrevonc.2013.03.010 PMID: 23602134
3. Proctor MJ, Horgan PG, Talwar D, Fletcher CD, Morrison DS, et al. (2013) Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study. Cancer 119:2325-32. doi: 10.1002/cncr.28018 PMID: 23575969
4. Pietila KO, Harmoinen AP, Jokiniitty J, Pasternack AI (1996) Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur.Heart J. 17:1345-9. PMID: 8880019
5. den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, et al. (2009) C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J.Neurol. 256:2003-8.
6. Zamani P, Schwartz GG, Olsson AG, Rifai N, Bao W, et al. (2013) Inflammatory Biomarkers, Death, and Recurrent Nonfatal Coronary Events After an Acute Coronary Syndrome in the MIRACL Study. J. Am.Heart Assoc. 2:e003103. doi: 10.1161/JAHA.112.003103 PMID: 23525424
7. Di Napoli M, Papa F, Bocola V (2001) C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 32:917-24. PMID: 11283392
8. Marsik C, Kazemi-Shirazi L, Schickbauer T, Winkler S, Joukhadar C, et al. (2008) C-reactive protein and all-cause mortality in a large hospital-based cohort. Clin.Chem. 54:343-9. PMID: 18156283
9. Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2010) C-reactive protein and all-cause mortality - the Copenhagen City Heart Study. Eur.Heart J. 31:1624-32. doi: 10.1093/eurheartj/ehq103 PMID: 20423919
10. Goldwasser P, Feldman J (1997) Association of serum albumin and mortality risk. J.Clin.Epidemiol. 50:693-703.
11. Grimm G, Haslacher H, Kampitsch T, Endler G, Marsik C, et al. (2009) Sex differences in the association between albumin and all-cause and vascular mortality. Eur.J.Clin.Invest. 39:860-5. doi: 10.1111/j.1365-2362.2009.02189.x PMID: 19645741
12. Gillum RF, Mussolino ME, Madans JH (2005) Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: the NHANES-I epidemiologic follow-up study. Ann.Epidemiol. 15:266-71. PMID: 15780773
13. Acanfora D, Gheorghiade M, Trojano L, Furgi G, Pasini E, et al. (2001) Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. Am.Heart J. 142:167-73. PMID: 11431674
14. Phillips AC, Carroll D, Gale CR, Drayson M, Batty GD (2011) Lymphocyte cell counts in middle age are positively associated with subsequent all-cause and cardiovascular mortality. QJM. 104:319-24. doi: 10.1093/qjmed/hcq199 PMID: 21051481
15. Sokunbi DO, Wadhwa NK, Suh H (1994) Vascular disease outcome and thrombocytosis in diabetic and nondiabetic end-stage renal disease patients on peritoneal dialysis. Adv.Perit.Dial. 10:77-80. PMID: 7999869
16. Proctor MJ, Talwar D, Balmar SM, O'Reilly DS, Foulis AK, et al. (2010) The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br.J.Cancer 103:870-6. doi: 10.1038/sj.bjc.6605855 PMID: 20717110
17. Ridker PM (2003) Cardiology Patient Page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 108:e81-e85. PMID: 14504253
18. Ridker PM (2008) High-sensitivity C-reactive protein as a predictor of all-cause mortality: implications for research and patient care. Clin.Chem. 54:234-7. doi: 10.1373/clinchem.2007.099465 PMID: 18223130
19. Lee S, Choe JW, Kim HK, Sung J (2011) High-sensitivity C-reactive protein and cancer. J.Epidemiol. 21:161-8. PMID: 21368452
20. Ko YJ, Kwon YM, Kim KH, Choi HC, Chun SH, Yoon HJ, et al. (2012) High-sensitivity C-reactive protein levels and cancer mortality. Cancer Epidemiol.Biomarkers Prev. 21:2076-86. doi: 10.1158/1055-9965. EPI-12-0611 PMID: 23136255
21. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, et al. (2011) A comparison of inflamma-tion-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur.J. Cancer 47:2633-41. doi: 10.1016/j.ejca.2011.03.028 PMID: 21724383
22. Bishop J, Clark D, Harris V, Stockton D, Sutton M (2004) Deprivation and Urban Rural Measurements in ISD. Summary Report. Edinburgh, ISD Geography, Population, Census and Deprivation Group.
23. McMillan DC (2013) Cancer and systemic inflammation: stage the tumour and stage the host. Br.J.Cancer 109:529. doi: 10.1038/bjc.2013.418 PMID: 23921279
24. Roxburgh CS, McMillan DC (2014) Cancer and systemic inflammation: treat the tumour and treat the host. Br.J.Cancer 110:1409-12. doi: 10.1038/bjc.2014.90 PMID: 24548867
25. Inoue Y, Iwata T, Okugawa Y, Kawamoto A, Hiro J, et al. (2013) Prognostic significance of a systemic inflammatory response in patients undergoing multimodality therapy for advanced colorectal cancer. Oncology 84:100-7. doi: 10.1159/000343822 PMID: 23147449
26. Gakis G, Todenhofer T, Renninger M, Schilling D, Sievert KD, et al. (2011) Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score. BJU.Int. 108:1800-5. doi: 10.1111/j.1464-410X.2011.10234.x PMID: 21507193
27. Lamb GW, Aitchison M, Ramsey S, Housley SL, McMillan DC (2012) Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems. Br.J.Cancer 106:279-83. doi: 10.1038/bjc.2011.556 PMID: 22166802
28. Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, et al. (2012) C-reactive protein, fibrinogen, and cardiovascular disease prediction. N.Engl.J.Med. 367:1310-20. doi: 10.1056/ NEJMoa1107477 PMID: 23034020
29. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, et al. (2010) 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J.Am.Coll.Cardiol. 56:e50-103. doi: 10.1016/j.jacc.2010.09.001 PMID: 21144964
30. Van Hemelrijck M, Eichholzer M, Faeh D, Rohrmann S (2012) Ability of a biomarker-based score to predict death from circulatory disease and cancer in NHANES III. BMC.Public Health 12:895. doi: 10.1186/1471-2458-12-895 PMID: 23092358
31. Maestripieri D, Hoffman CL (2011) Chronic stress, allostatic load, and aging in nonhuman primates. Dev.Psychopathol. 23:1187-95. doi: 10.1017/S0954579411000551 PMID: 22018089
32. Gay JL, Salinas JJ, Buchner DM, Mirza S, Kohl HW, et al. (2013) Meeting Physical Activity Guidelines is Associated with Lower Allostatic Load and Inflammation in Mexican Americans. J.Immigr.Minor. Health epub ahead of print.